C12Q 2326/30
2,2'-azinobis , i.e. abts
Official title: 2,2'-Azinobis (3-ethylbenzothiazoline-6-sulfonic acid), i.e. ABTS
C12Q2326/30 (2,2'-azinobis , i.e. abts) appears on 14 US grants and 0 published applications in this corpus.
Search patents in C12Q- Granted patents
- 14
- Published applications
- 0
- Assignees
- 5
- Inventors
- 10
- Latest grant
- 27 Jun 1995
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Diagnostic test for determining the antioxidant status of a sample27 Jun 1995US 5,427,951 ABritish Technology Group Limited
- Fecal occult blood test methods26 Nov 1991US 5,068,197 ALitmus Concepts, Inc.
- Fecal occult blood test reagents1 Oct 1991US 5,053,342 ALitmus Concepts, Inc.
- Developer for fecal occult blood tests20 Nov 1990US 4,971,914 ALitmus Concepts, Inc.
- Reagent composition for fecal occult blood tests17 Jul 1990US 4,942,132 ALitmus Concepts, Inc.
No published applications in this class yet.
Most cited
By later US patents
- Fecal occult blood test28US 4,615,982 A1986
- Fecal occult blood test method19US 4,937,197 ALitmus Concepts, Inc. · 1990
- Catalyzed colorimetric and fluorometric substrates for peroxidase enzyme determinations18US 4,521,511 ACo Enzyme Technology Ltd. · 1985
- Fecal occult blood test methods18US 4,939,097 ALitmus Concepts, Inc. · 1990
- Developer for fecal occult blood tests16US 4,971,914 ALitmus Concepts, Inc. · 1990